Ptc Therapeutics (PTCT) Asset Utilization Ratio (2013 - 2026)

Ptc Therapeutics' Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.33 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio fell 50.6% year-over-year to 0.33; the TTM figure through Jun 2026 stood at 0.33 (down 50.6% YoY), while the FY2025 annual figure was 0.75, up 67.78% from the prior year.
• Asset Utilization Ratio for Q2 2026 stood at 0.33, up from 0.29 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.73 in Q1 2025, with the low at 0.29 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.45 (2023), against an average of 0.48.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 78.63% in 2025, then sank 60.58% in 2026.
• Ptc Therapeutics' Asset Utilization Ratio stood at 0.43 in 2022, then jumped by 39.58% to 0.59 in 2023, then tumbled by 41.18% to 0.35 in 2024, then surged by 78.63% to 0.62 in 2025, then tumbled by 47.21% to 0.33 in 2026.
• Business Quant data shows PTCT's Asset Utilization Ratio at 0.33 in Q2 2026, 0.29 in Q1 2026, and 0.62 in Q4 2025.